The effects of fasting in Muslim patients taking warfarin

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 3, 2014, Pages 349-354

  Lai, Y F ^a   Cheen, M H H ^a   Lim, S H ^a   Yeo, F H I ^a   Nah, S C ^a   Kong, M C ^a   Mya, D ^a   Lee, L H ^a   Ng, H J ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Fasting; Humans; International normalized ratio; Muslim; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MENORRHAGIA; MIDDLE AGED; MOSLEM; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY; RAMADAN; SLEEP DEPRIVATION; YOUNG ADULT;

FASTING; HUMANS; INTERNATIONAL NORMALIZED RATIO; MUSLIM; WARFARIN;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FASTING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; ISLAM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM; WARFARIN; YOUNG ADULT;

EID: 84896783718     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12496     Document Type: Article

References (15)

1. McArthur MC, Dzintars EK, Phillips RB, Bushardt RL. Oral anticoagulation: a review of the current and emerging therapies. JAAPA 2011; 24: 60-6.
2. Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S-21S.
3. Holmes MV, Hunt BJ, Shearer MJ. The role of dietary vitamin K in the management of oral vitamin K antagonists. Blood Rev 2012; 26: 1-14.
4. Laliberte R, Chakrabarti S, Brodeur J. The influence of fasting on the disposition of warfarin in rats. J Pharmacol Exp Ther 1977; 200: 44-51.
5. Laliberté R, Chakrabarti S, Brodeur J. The influence of fasting and stress on the response of rats to warfarin. J Pharmacol Exp Ther 1976; 196: 194-203.
6. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-4.
7. Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Ann Hematol 2008; 87: 905-10.
8. Sobieraj-Teague M, Daniel D, Farrelly B, Coghlan D, Gallus A. Accuracy and clinical usefulness of the Coaguchek S and XS Point of Care devices when starting warfarin in a hospital outreach setting. Thromb Res 2009; 123: 909-13.
9. Lawrie AS, Hills J, Longair I, Green L, Gardiner C, Machin SJ, Cohen H. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients. Thromb Res 2012; 130: 110-4.
10. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
11. Ramadan: health effects of fasting. Lancet 2009; 374: 588.
12. Ziaee V, Razaei M, Ahmadinejad Z, Shaikh H, Yousefi R, Yarmohammadi L, Bozorgi F, Behjati MJ. The changes of metabolic profile and weight during Ramadan fasting. Singapore Med J 2006; 47: 409-14.
13. Hawk TL, Havrda DE. Effect of stress on international normalized ratio during warfarin therapy. Ann Pharmacother 2002; 36: 617-20.
14. Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. Chest 2004; 126: 1938-45.
15. Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 2008; 1: 84-91.